{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:12:28Z","timestamp":1788876748001,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32271418"],"award-info":[{"award-number":["32271418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272169"],"award-info":[{"award-number":["82272169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-026-02436-6","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:39:07Z","timestamp":1782229147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gnao1 acts as a gatekeeper to alleviate neuropathic pain by silencing pro-nociceptive signaling cascades"],"prefix":"10.1186","volume":"27","author":[{"given":"Jieyi","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00fc","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"1","key":"2436_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00045.2019","volume":"101","author":"NB Finnerup","year":"2021","unstructured":"Finnerup NB, Kuner R, Jensen TS (2021) Neuropathic Pain: From Mechanisms to Treatment. Physiol Rev 101(1):259\u2013301. https:\/\/doi.org\/10.1152\/physrev.00045.2019","journal-title":"Physiol Rev"},{"issue":"10289","key":"2436_CR2","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","volume":"397","author":"SP Cohen","year":"2021","unstructured":"Cohen SP, Vase L, Hooten WM (2021) Chronic pain: an update on burden, best practices, and new advances. Lancet 397(10289):2082\u20132097. https:\/\/doi.org\/10.1016\/S0140-6736(21)00393-7","journal-title":"Lancet"},{"issue":"2","key":"2436_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/j.pain.0000000000002688","volume":"164","author":"M Balanaser","year":"2023","unstructured":"Balanaser M, Carley M, Baron R, Finnerup NB, Moore RA, Rowbotham MC, Chaparro LE, Gilron I (2023) Combination pharmacotherapy for the treatment of neuropathic pain in adults: systematic review and meta-analysis. Pain 164(2):230\u2013251. https:\/\/doi.org\/10.1097\/j.pain.0000000000002688","journal-title":"Pain"},{"issue":"1","key":"2436_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bja.2023.04.021","volume":"131","author":"N Attal","year":"2023","unstructured":"Attal N, Bouhassira D, Colvin L (2023) Advances and challenges in neuropathic pain: a narrative review and future directions. Br J Anaesth 131(1):79\u201392. https:\/\/doi.org\/10.1016\/j.bja.2023.04.021","journal-title":"Br J Anaesth"},{"issue":"8","key":"2436_CR5","doi-asserted-by":"publisher","first-page":"CD013863","DOI":"10.1002\/14651858.CD013863.pub2","volume":"8","author":"BA Rosser","year":"2023","unstructured":"Rosser BA, Fisher E, Janjua S, Eccleston C, Keogh E, Duggan G (2023) Psychological therapies delivered remotely for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev 8(8):CD013863. https:\/\/doi.org\/10.1002\/14651858.CD013863.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2436_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cpt.19","volume":"97","author":"SM Helfert","year":"2015","unstructured":"Helfert SM, Reimer M, Hoper J, Baron R (2015) Individualized pharmacological treatment of neuropathic pain. Clin Pharmacol Ther 97(2):135\u2013142. https:\/\/doi.org\/10.1002\/cpt.19","journal-title":"Clin Pharmacol Ther"},{"key":"2436_CR7","doi-asserted-by":"publisher","first-page":"104482","DOI":"10.1016\/j.neubiorev.2021.12.005","volume":"134","author":"I Elman","year":"2022","unstructured":"Elman I, Pustilnik A, Borsook D (2022) Beating pain with psychedelics: Matter over mind? Neurosci Biobehav Rev 134:104482. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.12.005","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"2436_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11916-017-0629-5","volume":"21","author":"K Meacham","year":"2017","unstructured":"Meacham K, Shepherd A, Mohapatra DP, Haroutounian S (2017) Neuropathic Pain: Central vs. Peripheral Mechanisms. Curr Pain Headache Rep 21(6):28. https:\/\/doi.org\/10.1007\/s11916-017-0629-5","journal-title":"Curr Pain Headache Rep"},{"key":"2436_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1146\/annurev-pharmtox-010919-023238","volume":"61","author":"D Bamps","year":"2021","unstructured":"Bamps D, Vriens J, de Hoon J, Voets T (2021) TRP Channel Cooperation for Nociception: Therapeutic Opportunities. Annu Rev Pharmacol Toxicol 61:655\u2013677. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010919-023238","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"11","key":"2436_CR10","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/nm.3986","volume":"21","author":"C Peirs","year":"2015","unstructured":"Peirs C, Seal RP (2015) Targeting Toll-like receptors to treat chronic pain. Nat Med 21(11):1251\u20131252. https:\/\/doi.org\/10.1038\/nm.3986","journal-title":"Nat Med"},{"issue":"2","key":"2436_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","volume":"139","author":"AI Basbaum","year":"2009","unstructured":"Basbaum AI, Bautista DM, Scherrer G, Julius D (2009) Cellular and molecular mechanisms of pain. Cell 139(2):267\u2013284. https:\/\/doi.org\/10.1016\/j.cell.2009.09.028","journal-title":"Cell"},{"issue":"12","key":"2436_CR12","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1111\/bph.13957","volume":"175","author":"L-P Bernier","year":"2018","unstructured":"Bernier L-P, Ase AR, S\u00e9gu\u00e9la P (2018) P2X receptor channels in chronic pain pathways. Br J Pharmacol 175(12):2219\u20132230. https:\/\/doi.org\/10.1111\/bph.13957","journal-title":"Br J Pharmacol"},{"key":"2436_CR13","doi-asserted-by":"publisher","unstructured":"Dib-Hajj SD, Waxman SG (2019) Sodium channels in human pain disorders: genetics and pharmacogenomics. Annu Rev Neurosci 42. https:\/\/doi.org\/10.1146\/annurev-neuro-070918-050144","DOI":"10.1146\/annurev-neuro-070918-050144"},{"issue":"Suppl 1","key":"2436_CR14","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/j.pain.0000000000000368","volume":"157","author":"J Busserolles","year":"2016","unstructured":"Busserolles J, Tsantoulas C, Eschalier A, Lopez Garcia JA (2016) Potassium channels in neuropathic pain: advances, challenges, and emerging ideas. Pain 157(Suppl 1):S7\u2013S14. https:\/\/doi.org\/10.1097\/j.pain.0000000000000368","journal-title":"Pain"},{"issue":"10","key":"2436_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.tips.2022.06.004","volume":"43","author":"EK Harding","year":"2022","unstructured":"Harding EK, Zamponi GW (2022) The calcium channel terminator: hasta la vista pain. Trends Pharmacol Sci 43(10):801\u2013803. https:\/\/doi.org\/10.1016\/j.tips.2022.06.004","journal-title":"Trends Pharmacol Sci"},{"key":"2436_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-pharmtox-010818-021524","volume":"60","author":"K Bannister","year":"2020","unstructured":"Bannister K, Sachau J, Baron R, Dickenson AH (2020) Neuropathic Pain: Mechanism-Based Therapeutics. Annu Rev Pharmacol Toxicol 60:257\u2013274. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010818-021524","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2436_CR17","doi-asserted-by":"publisher","unstructured":"Simonetti M, Mauceri D (2023) Cellular and molecular mechanisms underlying pain chronicity. Cells 12(8). https:\/\/doi.org\/10.3390\/cells12081126","DOI":"10.3390\/cells12081126"},{"key":"2436_CR18","doi-asserted-by":"publisher","first-page":"104599","DOI":"10.1016\/j.neubiorev.2022.104599","volume":"136","author":"DM Zolezzi","year":"2022","unstructured":"Zolezzi DM, Alonso-Valerdi LM, Ibarra-Zarate DI (2022) Chronic neuropathic pain is more than a perception: Systems and methods for an integral characterization. Neurosci Biobehav Rev 136:104599. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104599","journal-title":"Neurosci Biobehav Rev"},{"issue":"12","key":"2436_CR19","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","volume":"16","author":"AS Hauser","year":"2017","unstructured":"Hauser AS, Attwood MM, Rask-Andersen M, Schioth HB, Gloriam DE (2017) Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discovery 16(12):829\u2013842. https:\/\/doi.org\/10.1038\/nrd.2017.178","journal-title":"Nat Rev Drug Discovery"},{"issue":"9","key":"2436_CR20","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.tibs.2021.05.002","volume":"46","author":"KA Martemyanov","year":"2021","unstructured":"Martemyanov KA (2021) Mechanisms of G\u03b2\u03b3 Release upon GPCR Activation. Trends Biochem Sci 46(9):703\u2013704. https:\/\/doi.org\/10.1016\/j.tibs.2021.05.002","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"2436_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1124\/mi.9.5.7","volume":"9","author":"LS Stone","year":"2009","unstructured":"Stone LS, Molliver DC (2009) In search of analgesia: emerging roles of GPCRs in pain. Mol Interv 9(5):234\u2013251. https:\/\/doi.org\/10.1124\/mi.9.5.7","journal-title":"Mol Interv"},{"issue":"7","key":"2436_CR22","doi-asserted-by":"publisher","first-page":"e28818","DOI":"10.1016\/j.heliyon.2024.e28818","volume":"10","author":"C Xu","year":"2024","unstructured":"Xu C, Wang Y, Ni H, Yao M, Cheng L, Lin X (2024) The role of orphan G protein-coupled receptors in pain. Heliyon 10(7):e28818. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28818","journal-title":"Heliyon"},{"issue":"49","key":"2436_CR23","doi-asserted-by":"publisher","first-page":"10535","DOI":"10.1523\/JNEUROSCI.0702-18.2018","volume":"38","author":"B-C Jiang","year":"2018","unstructured":"Jiang B-C, Zhang W-W, Yang T, Guo C-Y, Cao D-L, Zhang Z-J, Gao Y-J (2018) Demethylation of G-Protein-Coupled Receptor 151 Promoter Facilitates the Binding of Kr\u00fcppel-Like Factor 5 and Enhances Neuropathic Pain after Nerve Injury in Mice. J Neurosci 38(49):10535\u201310551. https:\/\/doi.org\/10.1523\/JNEUROSCI.0702-18.2018","journal-title":"J Neurosci"},{"issue":"5","key":"2436_CR24","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1097\/j.pain.0000000000002156","volume":"162","author":"B-C Jiang","year":"2021","unstructured":"Jiang B-C, Zhang J, Wu B, Jiang M, Cao H, Wu H, Gao Y-J (2021) G protein-coupled receptor GPR151 is involved in trigeminal neuropathic pain through the induction of G\u03b2\u03b3\/extracellular signal-regulated kinase-mediated neuroinflammation in the trigeminal ganglion. Pain 162(5):1434\u20131448. https:\/\/doi.org\/10.1097\/j.pain.0000000000002156","journal-title":"Pain"},{"issue":"11","key":"2436_CR25","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1093\/brain\/awab245","volume":"144","author":"L-P Xia","year":"2021","unstructured":"Xia L-P, Luo H, Ma Q, Xie Y-K, Li W, Hu H, Xu Z-Z (2021) GPR151 in nociceptors modulates neuropathic pain via regulating P2X3 function and microglial activation. Brain 144(11):3405\u20133420. https:\/\/doi.org\/10.1093\/brain\/awab245","journal-title":"Brain"},{"issue":"5","key":"2436_CR26","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1172\/JCI133270","volume":"130","author":"GL Yosten","year":"2020","unstructured":"Yosten GL, Harada CM, Haddock C, Giancotti LA, Kolar GR, Patel R, Guo C, Chen Z, Zhang J, Doyle TM, Dickenson AH, Samson WK, Salvemini D (2020) GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents. J Clin Investig 130(5):2587\u20132592. https:\/\/doi.org\/10.1172\/JCI133270","journal-title":"J Clin Investig"},{"key":"2436_CR27","doi-asserted-by":"publisher","first-page":"113248","DOI":"10.1016\/j.bbr.2021.113248","volume":"406","author":"S Armin","year":"2021","unstructured":"Armin S, Muenster S, Abood M, Benamar K (2021) GPR55 in the brain and chronic neuropathic pain. Behav Brain Res 406:113248. https:\/\/doi.org\/10.1016\/j.bbr.2021.113248","journal-title":"Behav Brain Res"},{"issue":"1","key":"2436_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s13311-022-01327-3","volume":"20","author":"Y Kim","year":"2023","unstructured":"Kim Y, Kim C, Lee H, Kim M, Zheng H, Lim JY, Yun H-I, Jeon M, Choi J, Hwang SW (2023) Gpr83 Tunes Nociceptor Function, Controlling Pain. Neurotherapeutics: J Am Soc Experimental Neurother 20(1):325\u2013337. https:\/\/doi.org\/10.1007\/s13311-022-01327-3","journal-title":"Neurotherapeutics: J Am Soc Experimental Neurother"},{"issue":"1","key":"2436_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12974-019-1458-8","volume":"16","author":"A Sayo","year":"2019","unstructured":"Sayo A, Konishi H, Kobayashi M, Kano K, Kobayashi H, Hibi H, Aoki J, Kiyama H (2019) GPR34 in spinal microglia exacerbates neuropathic pain in mice. J Neuroinflamm 16(1):82. https:\/\/doi.org\/10.1186\/s12974-019-1458-8","journal-title":"J Neuroinflamm"},{"issue":"12","key":"2436_CR30","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1038\/s41401-023-01135-1","volume":"44","author":"J-W Xu","year":"2023","unstructured":"Xu J-W, Xu X, Ling Y, Wang Y-C, Huang Y-J, Yang J-Z, Wang J-Y, Shen X (2023) Vincamine as an agonist of G-protein-coupled receptor 40 effectively ameliorates diabetic peripheral neuropathy in mice. Acta Pharmacol Sin 44(12):2388\u20132403. https:\/\/doi.org\/10.1038\/s41401-023-01135-1","journal-title":"Acta Pharmacol Sin"},{"issue":"639","key":"2436_CR31","doi-asserted-by":"publisher","first-page":"eabh2557","DOI":"10.1126\/scitranslmed.abh2557","volume":"14","author":"Y-K Xie","year":"2022","unstructured":"Xie Y-K, Luo H, Zhang S-X, Chen X-Y, Guo R, Qiu X-Y, Liu S, Wu H, Chen W-B, Zhen X-H, Ma Q, Tian J-L, Li S, Chen X, Han Q, Duan S, Shen C, Yang F, Xu Z-Z (2022) GPR177 in A-fiber sensory neurons drives diabetic neuropathic pain via WNT-mediated TRPV1 activation. Sci Transl Med 14(639):eabh2557. https:\/\/doi.org\/10.1126\/scitranslmed.abh2557","journal-title":"Sci Transl Med"},{"issue":"3","key":"2436_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.4103\/1673-5374.380905","volume":"19","author":"L Zhang","year":"2024","unstructured":"Zhang L, Tan X, Song F, Li D, Wu J, Gao S, Sun J, Liu D, Zhou Y, Mei W (2024) Activation of G-protein-coupled receptor 39 reduces neuropathic pain in a rat model. Neural Regen Res 19(3):687\u2013696. https:\/\/doi.org\/10.4103\/1673-5374.380905","journal-title":"Neural Regen Res"},{"issue":"346","key":"2436_CR33","doi-asserted-by":"publisher","first-page":"ra94","DOI":"10.1126\/scisignal.2005283","volume":"7","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Qin W, Qian Z, Liu X, Wang H, Gong S, Sun Y-G, Snutch TP, Jiang X, Tao J (2014) Peripheral pain is enhanced by insulin-like growth factor 1 through a G protein-mediated stimulation of T-type calcium channels. Sci Signal 7(346):ra94. https:\/\/doi.org\/10.1126\/scisignal.2005283","journal-title":"Sci Signal"},{"key":"2436_CR34","doi-asserted-by":"publisher","unstructured":"Mlost J, Bryk M, Starowicz K (2020) Cannabidiol for pain treatment: focus on pharmacology and mechanism of action. Int J Mol Sci 21(22). https:\/\/doi.org\/10.3390\/ijms21228870","DOI":"10.3390\/ijms21228870"},{"key":"2436_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-neuro-080317-061522","volume":"41","author":"G Corder","year":"2018","unstructured":"Corder G, Castro DC, Bruchas MR, Scherrer G (2018) Endogenous and Exogenous Opioids in Pain. Annu Rev Neurosci 41:453\u2013473. https:\/\/doi.org\/10.1146\/annurev-neuro-080317-061522","journal-title":"Annu Rev Neurosci"},{"issue":"7058","key":"2436_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/437491a","volume":"437","author":"MC Fishman","year":"2005","unstructured":"Fishman MC, Porter JA (2005) Pharmaceuticals: a new grammar for drug discovery. Nature 437(7058):491\u2013493","journal-title":"Nature"},{"key":"2436_CR37","doi-asserted-by":"publisher","unstructured":"Kumari P, Yadav A, Patel M, Yadav PN (2022) Targeting G protein coupled receptors for alleviating neuropathic pain. Prog Mol Biol Transl Sci 193(1). https:\/\/doi.org\/10.1016\/bs.pmbts.2022.06.004","DOI":"10.1016\/bs.pmbts.2022.06.004"},{"issue":"3","key":"2436_CR38","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1152\/jn.00720.2020","volume":"127","author":"H Feng","year":"2022","unstructured":"Feng H, Yuan Y, Williams MR, Roy AJ, Leipprandt JR, Neubig RR (2022) Mice with monoallelic GNAO1 loss exhibit reduced inhibitory synaptic input to cerebellar Purkinje cells. J Neurophysiol 127(3):607\u2013622. https:\/\/doi.org\/10.1152\/jn.00720.2020","journal-title":"J Neurophysiol"},{"key":"2436_CR39","doi-asserted-by":"publisher","unstructured":"Pei X, Zhang J, Wu L, L\u00fc B, Zhang X, Yang D, Liu J (2013) The down-regulation of GNAO1 and its promoting role in hepatocellular carcinoma. Biosci Rep 33(5). https:\/\/doi.org\/10.1042\/BSR20130001","DOI":"10.1042\/BSR20130001"},{"key":"2436_CR40","doi-asserted-by":"publisher","unstructured":"Dom\u00ednguez-Carral J, Ludlam WG, Junyent Segarra M, Fornaguera Marti M, Balsells S, Muchart J, \u010cokoli\u0107 Petrovi\u0107 D, Espinoza I, Ortigoza-Escobar JD, Martemyanov KA (2023) Severity of GNAO1-related disorder correlates with changes in G-protein function. Ann Neurol 94(5). https:\/\/doi.org\/10.1002\/ana.26758","DOI":"10.1002\/ana.26758"},{"issue":"6","key":"2436_CR41","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1073\/pnas.95.6.3269","volume":"95","author":"M Jiang","year":"1998","unstructured":"Jiang M, Gold MS, Boulay G, Spicher K, Peyton M, Brabet P, Srinivasan Y, Rudolph U, Ellison G, Birnbaumer L (1998) Multiple neurological abnormalities in mice deficient in the G protein Go. P Natl Acad Sci USA 95(6):3269\u20133274","journal-title":"P Natl Acad Sci USA"},{"issue":"5","key":"2436_CR42","doi-asserted-by":"publisher","first-page":"108718","DOI":"10.1016\/j.celrep.2021.108718","volume":"34","author":"BS Muntean","year":"2021","unstructured":"Muntean BS, Masuho I, Dao M, Sutton LP, Zucca S, Iwamoto H, Patil DN, Wang D, Birnbaumer L, Blakely RD, Grill B, Martemyanov KA (2021) G\u03b1o is a major determinant of cAMP signaling in the pathophysiology of movement disorders. Cell Rep 34(5):108718. https:\/\/doi.org\/10.1016\/j.celrep.2021.108718","journal-title":"Cell Rep"},{"issue":"1","key":"2436_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40478-024-01720-3","volume":"12","author":"J Xu","year":"2024","unstructured":"Xu J, Peng Q, Cai J, Shangguan J, Su W, Chen G, Sun H, Zhu C, Gu Y (2024) The Schwann cell-specific G-protein G\u03b1o (Gnao1) is a cell-intrinsic controller contributing to the regulation of myelination in peripheral nerve system. Acta Neuropathol Commun 12(1):24. https:\/\/doi.org\/10.1186\/s40478-024-01720-3","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"2436_CR44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3959(00)00276-1","volume":"87","author":"I Decosterd","year":"2000","unstructured":"Decosterd I, Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87(2):149\u2013158. https:\/\/doi.org\/10.1016\/S0304-3959(00)00276-1","journal-title":"Pain"},{"issue":"2","key":"2436_CR45","doi-asserted-by":"publisher","first-page":"e0150164","DOI":"10.1371\/journal.pone.0150164","volume":"11","author":"SE Harte","year":"2016","unstructured":"Harte SE, Meyers JB, Donahue RR, Taylor BK, Morrow TJ (2016) Mechanical Conflict System: A Novel Operant Method for the Assessment of Nociceptive Behavior. PLoS ONE 11(2):e0150164. https:\/\/doi.org\/10.1371\/journal.pone.0150164","journal-title":"PLoS ONE"},{"issue":"12","key":"2436_CR46","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1084\/jem.20180800","volume":"215","author":"ZJ Zhang","year":"2018","unstructured":"Zhang ZJ, Guo JS, Li SS, Wu XB, Cao DL, Jiang BC, Jing PB, Bai XQ, Li CH, Wu ZH, Lu Y, Gao YJ (2018) TLR8 and its endogenous ligand miR-21 contribute to neuropathic pain in murine DRG. J Exp Med 215(12):3019\u20133037. https:\/\/doi.org\/10.1084\/jem.20180800","journal-title":"J Exp Med"},{"issue":"1","key":"2436_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s10020-023-00667-w","volume":"29","author":"J Xu","year":"2023","unstructured":"Xu J, Zhang B, Cai J, Peng Q, Hu J, Askar P, Shangguan J, Su W, Zhu C, Sun H, Zhou S, Chen G, Yang X, Gu Y (2023) The transcription factor Stat-1 is essential for Schwann cell differentiation, myelination and myelin sheath regeneration. Mol Med 29(1):79. https:\/\/doi.org\/10.1186\/s10020-023-00667-w","journal-title":"Mol Med"},{"issue":"17","key":"2436_CR48","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1093\/hmg\/ddac077","volume":"31","author":"RB Parsons","year":"2022","unstructured":"Parsons RB, Kocinaj A, Ruiz Pulido G, Prendergast SA, Parsons AE, Facey PD, Hirth F (2022) Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway. Hum Mol Genet 31(17):2918\u20132933. https:\/\/doi.org\/10.1093\/hmg\/ddac077","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2436_CR49","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1038\/s41467-025-59849-1","volume":"16","author":"N Yousefpour","year":"2025","unstructured":"Yousefpour N, Tansley SN, Locke S, Sharif B, Parisien M, Bourojeni FB, Deamond H, Mathur V, Arana NR, Austin JS, Bourassa V, Wang C, Cabana VC, Wong C, Lister KC, Rodrigues R, St-Louis M, Paquet ME, Carroll MC, Andrews-Zwilling Y, Seguela P, Kania A, Yednock T, Mogil JS, De Koninck Y, Diatchenko L, Khoutorsky A, Ribeiro-da-Silva A (2025) Targeting C1q prevents microglia-mediated synaptic removal in neuropathic pain. Nat Commun 16(1):4590. https:\/\/doi.org\/10.1038\/s41467-025-59849-1","journal-title":"Nat Commun"},{"issue":"39","key":"2436_CR50","doi-asserted-by":"publisher","first-page":"27215","DOI":"10.1074\/jbc.M114.599712","volume":"289","author":"P Zhao","year":"2014","unstructured":"Zhao P, Lieu T, Barlow N, Metcalf M, Veldhuis NA, Jensen DD, Kocan M, Sostegni S, Haerteis S, Baraznenok V, Henderson I, Lindstrom E, Guerrero-Alba R, Valdez-Morales EE, Liedtke W, McIntyre P, Vanner SJ, Korbmacher C, Bunnett NW (2014) Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4. J Biol Chem 289(39):27215\u201327234. https:\/\/doi.org\/10.1074\/jbc.M114.599712","journal-title":"J Biol Chem"},{"key":"2436_CR51","doi-asserted-by":"publisher","first-page":"100047","DOI":"10.1016\/j.medidd.2020.100047","volume":"7","author":"K Montague-Cardoso","year":"2020","unstructured":"Montague-Cardoso K, Malcangio M (2020) Cathepsin S as a potential therapeutic target for chronic pain. Med Drug Discov 7:100047. https:\/\/doi.org\/10.1016\/j.medidd.2020.100047","journal-title":"Med Drug Discov"},{"issue":"5","key":"2436_CR52","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuron.2015.02.006","volume":"85","author":"IT Lee","year":"2015","unstructured":"Lee IT, Chang AS, Manandhar M, Shan Y, Fan J, Izumo M, Ikeda Y, Motoike T, Dixon S, Seinfeld JE, Takahashi JS, Yanagisawa M (2015) Neuromedin s-producing neurons act as essential pacemakers in the suprachiasmatic nucleus to couple clock neurons and dictate circadian rhythms. Neuron 85(5):1086\u20131102. https:\/\/doi.org\/10.1016\/j.neuron.2015.02.006","journal-title":"Neuron"},{"key":"2436_CR53","doi-asserted-by":"publisher","unstructured":"Rivera Quiles C, Simmons SC, Dodson O, Alday M, Camacho Fontanez N, Caico S, Garrison A, Shafieichaharberoud F, Huang X, Hu Q, Heller EA, Mazei-Robison MS (2025) Identification of a novel population of neuromedin S expressing neurons in the ventral tegmental area that promote morphine-elicited behavior. J neuroscience: Official J Soc Neurosci 45(13). https:\/\/doi.org\/10.1523\/JNEUROSCI.1662-24.2025","DOI":"10.1523\/JNEUROSCI.1662-24.2025"},{"issue":"4","key":"2436_CR54","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1523\/JNEUROSCI.22-04-01303.2002","volume":"22","author":"IE Bonilla","year":"2002","unstructured":"Bonilla IE, Tanabe K, Strittmatter SM (2002) Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J neuroscience: official J Soc Neurosci 22(4):1303\u20131315. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-04-01303.2002","journal-title":"J neuroscience: official J Soc Neurosci"},{"issue":"1","key":"2436_CR55","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13041-021-00854-y","volume":"14","author":"Y Katsuda","year":"2021","unstructured":"Katsuda Y, Tanaka K, Mori T, Narita M, Takeshima H, Kondo T, Yamabe Y, Matsufuji M, Sato D, Hamada Y, Yamaguchi K, Ushijima T, Inada E, Kuzumaki N, Iseki M, Narita M (2021) Histone modification of pain-related gene expression in spinal cord neurons under a persistent postsurgical pain-like state by electrocautery. Mol Brain 14(1):146. https:\/\/doi.org\/10.1186\/s13041-021-00854-y","journal-title":"Mol Brain"},{"issue":"2","key":"2436_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.tips.2006.12.003","volume":"28","author":"P Brumovsky","year":"2007","unstructured":"Brumovsky P, Shi TS, Landry M, Villar MJ, Hokfelt T (2007) Neuropeptide tyrosine and pain. Trends Pharmacol Sci 28(2):93\u2013102. https:\/\/doi.org\/10.1016\/j.tips.2006.12.003","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"2436_CR57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/joim.20118","volume":"298","author":"AA Nie","year":"2025","unstructured":"Nie AA, Taylor BK (2025) The pharmacotherapeutic potential of neuropeptide Y for chronic pain. J Intern Med 298(4):280\u2013296. https:\/\/doi.org\/10.1111\/joim.20118","journal-title":"J Intern Med"},{"issue":"10","key":"2436_CR58","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.peptides.2006.04.025","volume":"27","author":"PR Dobner","year":"2006","unstructured":"Dobner PR (2006) Neurotensin and pain modulation. Peptides 27(10):2405\u20132414. https:\/\/doi.org\/10.1016\/j.peptides.2006.04.025","journal-title":"Peptides"},{"issue":"2","key":"2436_CR59","doi-asserted-by":"publisher","first-page":"114801","DOI":"10.1016\/j.yexcr.2025.114801","volume":"453","author":"H Zheng","year":"2025","unstructured":"Zheng H, Zhang X, Li M, Wang Y, Guo S, Jiang M, Xu R, Huang Y, Ma Z (2025) The role and mechanism of fatty acid-binding protein 7 in spinal reactive astrocytes in prolonged postoperative pain induced by high-fat diet. Exp Cell Res 453(2):114801. https:\/\/doi.org\/10.1016\/j.yexcr.2025.114801","journal-title":"Exp Cell Res"},{"key":"2436_CR60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1744-8069-3-33","volume":"3","author":"RR Ji","year":"2007","unstructured":"Ji RR, Suter MR (2007) p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 3:33. https:\/\/doi.org\/10.1186\/1744-8069-3-33","journal-title":"Mol Pain"},{"issue":"6","key":"2436_CR61","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.neuron.2018.11.009","volume":"100","author":"G Chen","year":"2018","unstructured":"Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR (2018) Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain. Neuron 100(6):1292\u20131311. https:\/\/doi.org\/10.1016\/j.neuron.2018.11.009","journal-title":"Neuron"},{"key":"2436_CR62","doi-asserted-by":"publisher","first-page":"100028","DOI":"10.1016\/j.ynpai.2019.100028","volume":"6","author":"ZH Li","year":"2019","unstructured":"Li ZH, Cui D, Qiu CJ, Song XJ (2019) Cyclic nucleotide signaling in sensory neuron hyperexcitability and chronic pain after nerve injury. Neurobiol Pain 6:100028. https:\/\/doi.org\/10.1016\/j.ynpai.2019.100028","journal-title":"Neurobiol Pain"},{"issue":"23","key":"2436_CR63","doi-asserted-by":"publisher","first-page":"8959","DOI":"10.1523\/JNEUROSCI.3558-14.2015","volume":"35","author":"LS Nicol","year":"2015","unstructured":"Nicol LS, Dawes JM, La Russa F, Didangelos A, Clark AK, Gentry C, Grist J, Davies JB, Malcangio M, McMahon SB (2015) The role of G-protein receptor 84 in experimental neuropathic pain. J neuroscience: official J Soc Neurosci 35(23):8959\u20138969. https:\/\/doi.org\/10.1523\/JNEUROSCI.3558-14.2015","journal-title":"J neuroscience: official J Soc Neurosci"},{"issue":"1","key":"2436_CR64","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11302-021-09796-5","volume":"18","author":"WJ Ren","year":"2022","unstructured":"Ren WJ, Illes P (2022) Involvement of P2X7 receptors in chronic pain disorders. Purinergic Signal 18(1):83\u201392. https:\/\/doi.org\/10.1007\/s11302-021-09796-5","journal-title":"Purinergic Signal"},{"issue":"12","key":"2436_CR65","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1111\/bph.13957","volume":"175","author":"LP Bernier","year":"2018","unstructured":"Bernier LP, Ase AR, Seguela P (2018) P2X receptor channels in chronic pain pathways. Br J Pharmacol 175(12):2219\u20132230. https:\/\/doi.org\/10.1111\/bph.13957","journal-title":"Br J Pharmacol"},{"issue":"10","key":"2436_CR66","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1096\/fj.08-109355","volume":"22","author":"E Niederberger","year":"2008","unstructured":"Niederberger E, Geisslinger G (2008) The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy? FASEB J 22(10):3432\u20133442. https:\/\/doi.org\/10.1096\/fj.08-109355","journal-title":"FASEB J"},{"key":"2436_CR67","doi-asserted-by":"publisher","first-page":"941870","DOI":"10.3389\/fcell.2022.941870","volume":"10","author":"S Villaseca","year":"2022","unstructured":"Villaseca S, Romero G, Ruiz MJ, Perez C, Leal JI, Tovar LM, Torrejon M (2022) Galphai protein subunit: A step toward understanding its non-canonical mechanisms. Front Cell Dev Biol 10:941870. https:\/\/doi.org\/10.3389\/fcell.2022.941870","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"2436_CR68","doi-asserted-by":"publisher","first-page":"e10436","DOI":"10.7759\/cureus.10436","volume":"12","author":"AT Anthony","year":"2020","unstructured":"Anthony AT, Rahmat S, Sangle P, Sandhu O, Khan S (2020) Cannabinoid Receptors and Their Relationship With Chronic Pain: A Narrative Review. Cureus 12(9):e10436. https:\/\/doi.org\/10.7759\/cureus.10436","journal-title":"Cureus"},{"issue":"4","key":"2436_CR69","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.tips.2025.02.002","volume":"46","author":"BL Schmidt","year":"2025","unstructured":"Schmidt BL, De Logu F, Nassini R, Geppetti P, Bunnett NW (2025) Pain Signaling by GPCRs and RTKs. Trends Pharmacol Sci 46(4):372\u2013385. https:\/\/doi.org\/10.1016\/j.tips.2025.02.002","journal-title":"Trends Pharmacol Sci"},{"key":"2436_CR70","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev-pharmtox-051421-112259","volume":"63","author":"S Ghazisaeidi","year":"2023","unstructured":"Ghazisaeidi S, Muley MM, Salter MW (2023) Neuropathic Pain: Mechanisms, Sex Differences, and Potential Therapies for a Global Problem. Annu Rev Pharmacol Toxicol 63:565\u2013583. https:\/\/doi.org\/10.1146\/annurev-pharmtox-051421-112259","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02436-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02436-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02436-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:02:40Z","timestamp":1788876160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02436-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2436"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02436-6","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were approved by the Ethics Committee of Nantong University and carried out in accordance with the NIH Guide for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"222"}}